US Patent Issued on Feb. 3 for "Oral vaccine via dental bacteria and emitted peptides to prevent COVID-19 infection" (Virginia Inventor)

ALEXANDRIA, Va., Feb. 3 -- United States Patent no. 12,539,328, issued on Feb. 3.

"Oral vaccine via dental bacteria and emitted peptides to prevent COVID-19 infection" was invented by David Kotlyar (Sterling, Va.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed is a pharmaceutical composition to prevent transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the pharmaceutical composition comprising: genetically modified bacteria; sequences of small peptides; and pharmaceutical excipients, wherein the genetically modified oral bacteria are modified to translate, produce, and emit the sequences of small peptides which neutralize SARS-CoV-2 against COVID-19, wherein transgenic tec...